Securing Pharmaceutical Innovation From Research to Production

This whitepaper presents an analysis of the cybersecurity challenges faced by pharmaceutical organizations, particularly in the context of securing intellectual property, Good Manufacturing Practice (GMP) environments, and clinical systems against modern cyber threats. It outlines the increasing targeting of these organizations by ransomware groups and nation-state actors, which complicates the cybersecurity landscape due to growing regulatory requirements and the expansion of IT, operational technology (OT), cloud, and third-party ecosystems. The document discusses the limitations of traditional security tools that often lack the necessary visibility and automation to effectively detect and respond to these threats. Furthermore, it details how a unified AI-native cybersecurity platform can enhance threat detection, automate responses, and ensure compliance, thereby protecting research and development, GMP manufacturing, clinical systems, and global operations. The whitepaper emphasizes the importance of a comprehensive approach to cybersecurity in the pharmaceutical sector.